Sonoma Pharmaceuticals Inc logo

Sonoma Pharmaceuticals Inc

$ 2.13 -0.04 (-1.84%) 08:08 PM EST
P/E:
At Loss
P/B:
0.87
Market Cap:
$ 6.61M
Enterprise V:
$ 2.10M
Volume:
5.12K
Avg Vol (2M):
53.26K
Also Trade In:
Volume:
5.12K
Market Cap $:
6.61M
PE Ratio:
At Loss
Avg Vol (2-Month):
53.26K
Enterprise Value $:
2.10M
PB Ratio:
0.87
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries.

Financials

SNOA's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SNOA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 12.927
EPS (TTM) ($) -1.71
Beta 0.88
Volatility % 62.8
14-Day RSI 25.07
14-Day ATR ($) 0.159478
20-Day SMA ($) 2.64158
12-1 Month Momentum % -52.85
52-Week Range ($) 2.07 - 7.2
Shares Outstanding (Mil) 3.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sonoma Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Sonoma Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.